U.S. flag

An official website of the United States government

NM_000546.6(TP53):c.785G>T (p.Gly262Val) AND Hereditary cancer-predisposing syndrome

Germline classification:
Uncertain significance (2 submissions)
Last evaluated:
Jun 18, 2022
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000492458.5

Allele description [Variation Report for NM_000546.6(TP53):c.785G>T (p.Gly262Val)]

NM_000546.6(TP53):c.785G>T (p.Gly262Val)

Gene:
TP53:tumor protein p53 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
17p13.1
Genomic location:
Preferred name:
NM_000546.6(TP53):c.785G>T (p.Gly262Val)
HGVS:
  • NC_000017.11:g.7673835C>A
  • NG_017013.2:g.18716G>T
  • NM_000546.6:c.785G>TMANE SELECT
  • NM_001126112.3:c.785G>T
  • NM_001126113.3:c.785G>T
  • NM_001126114.3:c.785G>T
  • NM_001126115.2:c.389G>T
  • NM_001126116.2:c.389G>T
  • NM_001126117.2:c.389G>T
  • NM_001126118.2:c.668G>T
  • NM_001276695.3:c.668G>T
  • NM_001276696.3:c.668G>T
  • NM_001276697.3:c.308G>T
  • NM_001276698.3:c.308G>T
  • NM_001276699.3:c.308G>T
  • NM_001276760.3:c.668G>T
  • NM_001276761.3:c.668G>T
  • NP_000537.3:p.Gly262Val
  • NP_000537.3:p.Gly262Val
  • NP_001119584.1:p.Gly262Val
  • NP_001119585.1:p.Gly262Val
  • NP_001119586.1:p.Gly262Val
  • NP_001119587.1:p.Gly130Val
  • NP_001119588.1:p.Gly130Val
  • NP_001119589.1:p.Gly130Val
  • NP_001119590.1:p.Gly223Val
  • NP_001263624.1:p.Gly223Val
  • NP_001263625.1:p.Gly223Val
  • NP_001263626.1:p.Gly103Val
  • NP_001263627.1:p.Gly103Val
  • NP_001263628.1:p.Gly103Val
  • NP_001263689.1:p.Gly223Val
  • NP_001263690.1:p.Gly223Val
  • LRG_321t1:c.785G>T
  • LRG_321:g.18716G>T
  • LRG_321p1:p.Gly262Val
  • NC_000017.10:g.7577153C>A
  • NM_000546.4:c.785G>T
  • NM_000546.5:c.785G>T
Protein change:
G103V
Links:
dbSNP: rs1131691025
NCBI 1000 Genomes Browser:
rs1131691025
Molecular consequence:
  • NM_000546.6:c.785G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126112.3:c.785G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126113.3:c.785G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126114.3:c.785G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126115.2:c.389G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126116.2:c.389G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126117.2:c.389G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001126118.2:c.668G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276695.3:c.668G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276696.3:c.668G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276697.3:c.308G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276698.3:c.308G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276699.3:c.308G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276760.3:c.668G>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001276761.3:c.668G>T - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Hereditary cancer-predisposing syndrome
Synonyms:
Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000581135Ambry Genetics
criteria provided, single submitter

(Ambry Variant Classification Scheme 2023)
Uncertain significance
(Dec 4, 2015)
germlineclinical testing

Citation Link,

SCV002581997Genome-Nilou Lab
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significance
(Jun 18, 2022)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenonot providednot providednot providednot providednot providedclinical testing
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From Ambry Genetics, SCV000581135.6

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

The p.G262V variant (also known as c.785G>T), located in coding exon 7 of the TP53 gene, results from a G to T substitution at nucleotide position 785. The glycine at codon 262 is replaced by valine, an amino acid with dissimilar properties. This variant is in the DNA binding domain of the TP53 protein and is reported to have loss of transactivation capacity in yeast based assays (IARC TP53 database; Kato S et al. Proc Natl Acad Sci USA. 2003 Jul 8;100(14):8424-9).This variant was not reported in population based cohorts in the following databases: Database of Single Nucleotide Polymorphisms (dbSNP), NHLBI Exome Sequencing Project (ESP), and 1000 Genomes Project. In the ESP, this variant was not observed in 6502 samples (13004 alleles) with coverage at this position. To date, this alteration has been detected with an allele frequency of approximately 0.0005% (greater than 200000 alleles tested) in our clinical cohort. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this variant remains unclear.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Genome-Nilou Lab, SCV002581997.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenonot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 13, 2024